Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Aaron Lindstrom"'
Autor:
Dalin Zhang, Aaron Lindstrom, Edward J Kim, Chang-il Hwang, Madison Lee Hall, Tzu-Yin Lin, Yuanpei Li
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
To date, driver genes for pancreatic cancer treatment are difficult to pursue therapeutically. Targeting mutated KRAS, the most renowned driver gene in pancreatic cancer, is an active area of study. We discovered a gene named SEMA3C was highly expres
Externí odkaz:
https://doaj.org/article/1f4716d9ebe94140ae794f6acb6f3277
Autor:
Zhao Ma, Jin Li, Kai Lin, Mythili Ramachandran, Dalin Zhang, Megan Showalter, Cristabelle De Souza, Aaron Lindstrom, Lucas N. Solano, Bei Jia, Shiro Urayama, Yuyou Duan, Oliver Fiehn, Tzu-yin Lin, Minyong Li, Yuanpei Li
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Integration of the unique advantages of the fields of drug discovery and drug delivery is invaluable for the advancement of drug development. Here, the authors generate single-drug nanoparticles by hybridising lysomotropic detergents and the bisamino
Externí odkaz:
https://doaj.org/article/c1bb3fa64a58463a9a7b7509b2e89b61
Autor:
Zhao Ma, Jin Li, Kai Lin, Mythili Ramachandran, Dalin Zhang, Megan Showalter, Cristabelle De Souza, Aaron Lindstrom, Lucas N. Solano, Bei Jia, Shiro Urayama, Yuyou Duan, Oliver Fiehn, Tzu-yin Lin, Minyong Li, Yuanpei Li
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-22419-2
Externí odkaz:
https://doaj.org/article/0a0cf375b21a4304ae95b86233cb29d9
Autor:
Megan R. Showalter, Bei Jia, Jin Li, Minyong Li, Cristabelle De Souza, Yuanpei Li, Tzu-yin Lin, Kai Lin, Zhao Ma, Yuyou Duan, Shiro Urayama, Mythili Ramachandran, Dalin Zhang, Oliver Fiehn, Aaron Lindstrom, Lucas N. Solano
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-12 (2020)
Nature communications, vol 11, iss 1
Nature Communications
Nature communications, vol 11, iss 1
Nature Communications
Integration of the unique advantages of the fields of drug discovery and drug delivery is invaluable for the advancement of drug development. Here we propose a self-delivering one-component new-chemical-entity nanomedicine (ONN) strategy to improve c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5511043fa508628c5c3683ea67e5875d
https://doi.org/10.1038/s41467-020-18399-4
https://doi.org/10.1038/s41467-020-18399-4
Publikováno v:
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnologyREFERENCES. 12(3)
Nanomedicines have made important contributions in the development of cancer therapies due to their tumor selectivity, multifunctionality, and synergistic effect between the payloads. In addition to the required pharmaceutical ingredients, nanomedici
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa58f1321fe7646a3ce60796f4593cdb
https://pubmed.ncbi.nlm.nih.gov/31840421
https://pubmed.ncbi.nlm.nih.gov/31840421
Publikováno v:
Bioconjugate chemistry. 30(6)
As unique molecules with both therapeutic and diagnostic properties, porphyrin derivatives have been extensively employed for cancer treatment. Porphyrins not only show powerful phototherapeutic effects (photodynamic and photothermal therapies), but
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043cdcd1a4ba919eb9d0bb90f94110d6
https://pubmed.ncbi.nlm.nih.gov/31023011
https://pubmed.ncbi.nlm.nih.gov/31023011
Publikováno v:
Theranostics, vol 9, iss 25
Theranostics
Theranostics
Peptide-based materials hold great promise as immunotherapeutic agents for the treatment of many malignant cancers. Extensive studies have focused on the development of peptide-based cancer vaccines and delivery systems by mimicking the functional do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9d703efd293762e16872cd9bdd87fe4
https://escholarship.org/uc/item/7jv3p18t
https://escholarship.org/uc/item/7jv3p18t
Autor:
Cristabelle De Souza, Yuyou Duan, Lucas N. Solano, Shiro Urayama, Mythili Ramachandran, Zhao Ma, Dalin Zhang, Kai Lin, Oliver Fiehn, Bei Jia, Jin Li, Tzu-yin Lin, Aaron Lindstrom, Megan R. Showalter, Minyong Li, Yuanpei Li
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-1 (2021)
Nature Communications
Nature Communications
Integration of the unique advantages of the fields of drug discovery and drug delivery is invaluable for the advancement of drug development. Here we propose a self-delivering one-component new-chemical-entity nanomedicine (ONN) strategy to improve c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce5488fea75faa5a7c1b834df7e6be14
https://doaj.org/article/0a0cf375b21a4304ae95b86233cb29d9
https://doaj.org/article/0a0cf375b21a4304ae95b86233cb29d9
Autor:
Shaoming Zhu, Mythili Ramachandran, Zhao Ma, Aaron Lindstrom, Jin Li, Menghuan Tang, Yuanpei Li, Tzu-yin Lin, Lanwei Zhang, Kai Lin
Publikováno v:
Advanced Functional Materials. 31:2008460
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2529955071dd9190bac771a647c5140
https://doi.org/10.1002/adfm.202008460
https://doi.org/10.1002/adfm.202008460
Publikováno v:
Medicine in Drug Discovery, Vol 6, Iss, Pp 100040-(2020)
Nanomedicine that combines technology with medical diagnostics and therapeutics is now advancing to greater heights for its significant potential in drug delivery. Epigenetic modifications that alter gene expressions patterns are often associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39eef0dff7778a440495cd2654970838
https://doi.org/10.1016/j.medidd.2020.100040
https://doi.org/10.1016/j.medidd.2020.100040